Tags: Policy
SOCMA advocated on our member companies’ behalf with EPA’s Office of Land and Emergency Management (OLEM) about the impact that changes to the Manufacturing Process Unit (MPU) Exclusion under the Resource Conservation and Recovery Act (RCRA) have on specialty chemical facilities. The meeting also focused on the Definition of Solid Waste and the impeding backlog of hazardous secondary waste incineration.
May 5, 2023
Yesterday, The House of Representatives passed a bill titled H.R. 1 - The Lower Energy Costs Act, which focuses on securing energy supply for the U.S.
March 31, 2023
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) significantly expands FDA’s rulemaking and enforcement authority over cosmetics and creates substantial new compliance obligations for manufacturers, packers, and distributors of cosmetics intended for sale in the United States.
March 30, 2023
The Toxic Substances Control Act (TSCA) including the 2016 Lautenberg Chemical Safety Act (LCSA) amendments grant the Environmental Protection Agency (EPA) the authority to collect fees from chemical manufacturers and importers to offset up to 25% of the costs associated with the overall implementation and administration of TSCA.
January 20, 2023
On September 7, SOCMA staff and three member companies met with the White House Office of Management and Budget (OMB) to present the specialty chemical industry’s unique perspective on the soon to be released proposed TSCA Fees Rule.
September 8, 2022
As the specialty chemicals industry anticipates new policy and regulations coming under the Biden Administration, the Society of Chemical Manufacturers & Affiliates (SOCMA) is hosting its Policy Webinar Series throughout April to focus these key topics that are crucial to its membership and the value chain.
March 30, 2021
The Society of Chemical Manufacturers & Affiliates (SOCMA) today welcomes the passage of legislation that includes a 3-year reauthorization of the Department of Homeland Security’s (DHS) Chemical Facilities Anti-Terrorism Standards (CFATS).
July 20, 2020
The Office of the U.S. Trade Representative (USTR) has announced that USTR is requesting public comments by June 25, 2020 on further modifications to remove Section 301 duties from additional Chinese-origin medical-care products, including pharmaceuticals and chemicals to make pharmaceuticals. SOCMA will submit comments to the docket and as such, requests input from members via the SOCMA 301 COVID-19 Data Sheet (page 3) for inclusion in SOCMA 301 COVID-19 Comments.
March 31, 2020
SOCMA appreciates the opportunity to submit comments on the U.S. Environmental Protection Agency’s framework document entitled: “TSCA New Chemical Determinations: A Working Approach for Making Determinations under TSCA Section 5”.
February 18, 2020
